Pyridine → HCID 68870800, compound

HRID 1984811Notes

Reaction equation

HRID 1984811 reaction equation
[CH3:1][O:2][C:3](=[O:36])[C@@H:4]([NH:25][C:26](=[O:35])[C:27]1[CH:32]=[C:31]([Br:33])[CH:30]=[CH:29][C:28]=1[NH2:34])[CH2:5][C:6]1[CH:11]=[CH:10][C:9]([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=2[O:18][C:19]2[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=2)=[CH:8][CH:7]=1.[CH3:37][CH:38]([CH2:43][C:44]([CH3:47])([CH3:46])C)[CH2:39][C:40](Cl)=[O:41].N1C=CC=C[CH:49]=1>C(Cl)Cl>[Br:33][C:31]1[CH:30]=[CH:29][C:28]([NH:34][C:40](=[O:41])[CH2:39][C:38]([CH3:37])([CH3:49])[CH2:43][CH:44]([CH3:46])[CH3:47])=[C:27]([CH:32]=1)[C:26]([NH:25][C@@H:4]([CH2:5][C:6]1[CH:7]=[CH:8][C:9]([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=2[O:18][C:19]2[CH:20]=[CH:21][CH:22]=[CH:23][CH:24]=2)=[CH:10][CH:11]=1)[C:3]([OH:36])=[O:2])=[O:35].[CH3:1][O:2][C:3](=[O:36])[C@@H:4]([NH:25][C:26](=[O:35])[C:27]1[CH:32]=[C:31]([Br:33])[CH:30]=[CH:29][C:28]=1[NH:34][C:40](=[O:41])[CH2:39][C:38]([CH3:37])([CH3:49])[CH2:43][CH:44]([CH3:46])[CH3:47])[CH2:5][C:6]1[CH:7]=[CH:8][C:9]([C:12]2[CH:17]=[CH:16][CH:15]=[CH:14][C:13]=2[O:18][C:19]2[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=2)=[CH:10][CH:11]=1

Participants

6

Procedure

A solution of (2S)-(2-amino-5-bromo-benzoylamino)-3-(2′-phenoxy-biphenyl-4-yl)-propionic acid methyl ester (54.5 mg, 0.10 mmol) from example 294 in 1 mL dry CH2Cl2 was treated with 3,5,5-trimethylhexanoyl chloride (1.2 eq., 23 μL, 0.12 mmol) and pyridine (1.5 eq., 12 μL, 0.15 mmol) in succession and stirred under an atmosphere of dry N2 for one hour, then concentrated in vacuo. The crude residue was purified by flash column chromatography (hexanes, EtOAc) to afford the desired amide, (2S)-[5-bromo-2-(3,3,5-trimethyl-hexanoylamino)-benzoylamino]-3-(2′-phenoxy-biphenyl-4-yl)-propionic acid methyl ester (68 mg). The methyl ester (20 mg, 29 μmol) was dissolved in 2.0 mL THF and 0.5 mL MeOH and saponified with 2N aqueous LiOH solution (0.25 mL), as described in general procedure C, to afford the title compound, (2S)-[5-bromo-2-(3,3,5-trimethyl-hexanoylamino)-benzoylamino]-3-(2′-phenoxy-biphenyl-4-yl)-propionic acid (20 mg), as a white solid.

Workup

  1. concentrationconcentrated in vacuo
  2. customThe crude residue was purified by flash column chromatography (hexanes, EtOAc)

Sources & evidence

ORD record
ord-6293918b6ad04656b0be0fee4349a9fe
Source dataset
uspto-grants-2009_06
Patent number
US07544699B2

Reaction notes

Loading…